Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Richard Pfenniger
AddedMar 31, 2024
UpdatedMay 1, 2026
Richard Pfenniger

Richard Pfenniger

Board Member, GeneDx Holdings

Richard Pfenniger's Career

GeneDx Holdings
GeneDx Holdings

Stamford, CT, US

Board Member· Board
Asensus Surgical
Asensus Surgical

Durham, NC, US

Board Member· Board
Opko Health
Opko Health

Miami, FL, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Richard Pfenniger's Career

GeneDx Holdings
GeneDx Holdings
Public$941M9192017Stamford, CT, US
Board Member· Board

Leadership at GeneDx Holdings

Keith MeisterKeith MeisterBoard Member
Katherine StuelandKatherine StuelandCEO
Eric SchadtEric SchadtFounder

Similar to GeneDx Holdings

InvitaeInvitaeSan Francisco, CA, USGenetic Testingest. 2010InvitaeSan Francisco, CA, US · est. 2010

Invitae Corp., a global genetic information company, specializes in diagnostics, oncology, pediatrics, and hereditary screening.

Public · $2.5B1.7k
GeneicdGeneicdScottsdale, AZ, USBiotechnology, Genomicsest. 2019GeneicdScottsdale, AZ, US · est. 2019

GENEICD: A leading biotech firm innovating in genomics for improved patient health.

Seed · $152.5k7
GeneticaGeneticaSan Francisco, CA, USGene Testingest. 2017GeneticaSan Francisco, CA, US · est. 2017

San Francisco-based Genetica pioneers in gene testing technology for precision medicine in Asia.

Seed · $2.5M75
Gene SolutionsGene SolutionsCharlottesville, VA, USDiagnostics, Genomicsest. 2006Gene SolutionsCharlottesville, VA, US · est. 2006

Gene Solutions: Identifying disease-causing mutations through mitochondrial genomics.

Seed · $2.9M8
Asensus Surgical
Asensus Surgical
Public$454.6M1972006Durham, NC, US
Board Member· Board

Leadership at Asensus Surgical

David MilneDavid MilneBoard Member
Matt RiekeMatt RiekeBoard Member
Anthony FernandoAnthony FernandoCEO
Richard StackRichard StackCo-Founder
Bill StarlingBill StarlingBoard Member

Similar to Asensus Surgical

Intuitive SurgicalIntuitive SurgicalSunnyvale, CA, USMedical Devices, Surgical Systemsest. 1995Intuitive SurgicalSunnyvale, CA, US · est. 1995

Intuitive Surgical, Inc.: A global American corporation designing, manufacturing, and marketing advanced surgical systems.

Public12.1k
surgical.aisurgical.aiBoston, MA, USSurgical Solutionsest. 2011surgical.aiBoston, MA, US · est. 2011

Surgical.ai: Building innovative healthcare tech solutions.

7
Intuitive SurgicalIntuitive SurgicalSunnyvale, CA, USMedical Devices, Surgical SystemsIntuitive SurgicalSunnyvale, CA, US

Intuitive Surgical, Inc. develops and markets innovative medical products for minimally invasive care globally.

Public12.1k
XSurgical RoboticsXSurgical RoboticsCambridge, MA, USSurgical Instruments, Surgical Robotsest. 2009XSurgical RoboticsCambridge, MA, US · est. 2009

XSurgical: Innovating surgical practice with advanced robotic instruments and technology.

Angel · $54.8k30
Opko Health
Opko Health
Public$436M4.2k1991Miami, FL, US
Board Member· Board

Leadership at Opko Health

Phil FrostPhil FrostBoard Member
Jonathan R. CohenJonathan R. CohenBoard Member
Elias A. Zerhouni M.d.Elias A. Zerhouni M.d.Board Member
Jane HsiaoJane HsiaoBoard Member

Similar to Opko Health

Merck & CO INC Cedear EAC 5 REMerck & CO INC Cedear EAC 5 RERahway, NJ, USPharmaceuticalsest. 1891Merck & CO INC Cedear EAC 5 RERahway, NJ, US · est. 1891

Global healthcare company in Rahway, NJ, offering pharmaceutical and animal health products and solutions.

Public · $8.2M69k
ViatrisViatrisCanonsburg, PA, USPharmaceuticalsest. 2020ViatrisCanonsburg, PA, US · est. 2020

Viatris Inc.: A global healthcare company producing pharmaceuticals for a wide range of diseases worldwide.

Public37k
Bayer PharmaceuticalsBayer PharmaceuticalsBerlin, Berlin, DEDrugs, Pharmaceuticalsest. 2003Bayer PharmaceuticalsBerlin, Berlin, DE · est. 2003

Bayer Pharmaceuticals: A global enterprise specializing in biochemical research and drug manufacturing since 2008.

Public10k
GSKGSKLondon, Greater London, GBBiotech, Pharmaceuticalsest. 2000GSKLondon, Greater London, GB · est. 2000

GSK PLC: A British multinational firm innovating in pharmaceuticals, biotech, and health products.

Public · $25.5M69.4k

Richard Pfenniger's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Richard Pfenniger

Richard J. NigonRichard J. NigonBoard Member · NTICR. John FletcherR. John FletcherBoard Member · OptinoseRobert R. SchmidtRobert R. SchmidtBoard Member · One MedicalChristine A. TsingosChristine A. TsingosBoard Member · Telesis BioRalph SnydermanRalph SnydermanBoard Member · CareDxRobert BalogRobert BalogCo-Founder · BioCeryx